BIO 2026 | John Gill | Abzena

In the fast-moving landscape of cell culture and cell line development, communication bottlenecks can stall life-saving therapies. How much does a vendor's physical and operational proximity affect project success?

In this live episode from the floor of BIO International Convention 2026, we visit the Abzena booth to chat with John Gill, a 30-year industry veteran who has recently stepped into the organization. John brings a deep technical background to the table, having spent decades mastering cell culture, scaling up development platforms.

John sits down with Aaron to discuss his transition to the CDMO side of the industry, the mechanics of vendor benchmarking, and why Abzena's localized infrastructure serves as an essential framework for biopharma companies looking to compress their development timelines.